Pulmatrix Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pulmatrix Inc with three other
companies in this sector in UNITED STATES :
China Pharma Holdings, Inc.
sales of $10.87 million
ProPhase Labs Inc
of which 100%
was Pharmaceutical produc).
During the second
quarter of 2021, sales at Pulmatrix Inc totalled
This is a drop of 35.6%
from the $3.50 million in sales at the company during the second quarter in 2020.
During the first two
quarters of 2021, sales totalled $3.64 million, which is
than through the first two quarters of 2020.
Pulmatrix Inc reported sales of $12.63 million
December of 2020.
increase of 59.7%
versus 2019, when the company's sales were $7.91 million.